Stock Track | Natera Soars 5.36% in Pre-Market on Record Q4 Results and Robust Outlook

Stock Track

28 Feb

Natera (NASDAQ: NTRA) stock surged 5.36% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and bullish 2025 guidance.

The key highlights driving Natera's stock rally include:

Record revenue of $476 million in Q4 2024, reflecting a 53% year-over-year increase, driven by strong growth in their Signatera test volumes and improved average selling prices (ASPs).
Gross margins expanded significantly to 63% in Q4 2024, up from 51% in the prior year, showcasing improved cost management and pricing strategies.
Positive cash flow generation of $46 million in Q4 2024, contributing to a total of $86 million for the year, demonstrating Natera's financial strength.
Robust 2025 revenue guidance ranging from $1.87 billion to $1.95 billion, reflecting continued momentum and growth potential.
Expanded Medicare coverage for Signatera in non-small cell lung cancer, opening new market opportunities and potential revenue streams.

Additionally, several analysts have raised their price targets and reiterated Buy ratings on Natera's stock, citing the company's strong Q4 performance, promising growth prospects, and strategic initiatives. These positive analyst views have further fueled the stock's pre-market rally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1159773109"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159773109\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1159773109?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159773109","market":"hk","top_or_hot":-1,"title":"Stock Track | Natera Soars 5.36% in Pre-Market on Record Q4 Results and Robust Outlook","media":"Stock Track","content":"<p>Natera (NASDAQ: NTRA) stock surged 5.36% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and bullish 2025 guidance.</p>\n\n<p>The key highlights driving Natera's stock rally include:\n<ul>\n<li>Record revenue of $476 million in Q4 2024, reflecting a 53% year-over-year increase, driven by strong growth in their Signatera test volumes and improved average selling prices (ASPs).</li>\n<li>Gross margins expanded significantly to 63% in Q4 2024, up from 51% in the prior year, showcasing improved cost management and pricing strategies.</li>\n<li>Positive cash flow generation of $46 million in Q4 2024, contributing to a total of $86 million for the year, demonstrating Natera's financial strength.</li>\n<li>Robust 2025 revenue guidance ranging from $1.87 billion to $1.95 billion, reflecting continued momentum and growth potential.</li>\n<li>Expanded Medicare coverage for Signatera in non-small cell lung cancer, opening new market opportunities and potential revenue streams.</li>\n</ul>\n</p>\n\n<p>Additionally, several analysts have raised their price targets and reiterated Buy ratings on Natera's stock, citing the company's strong Q4 performance, promising growth prospects, and strategic initiatives. These positive analyst views have further fueled the stock's pre-market rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Natera Soars 5.36% in Pre-Market on Record Q4 Results and Robust Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Natera Soars 5.36% in Pre-Market on Record Q4 Results and Robust Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-28 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Natera (NASDAQ: NTRA) stock surged 5.36% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and bullish 2025 guidance.</p>\n\n<p>The key highlights driving Natera's stock rally include:\n<ul>\n<li>Record revenue of $476 million in Q4 2024, reflecting a 53% year-over-year increase, driven by strong growth in their Signatera test volumes and improved average selling prices (ASPs).</li>\n<li>Gross margins expanded significantly to 63% in Q4 2024, up from 51% in the prior year, showcasing improved cost management and pricing strategies.</li>\n<li>Positive cash flow generation of $46 million in Q4 2024, contributing to a total of $86 million for the year, demonstrating Natera's financial strength.</li>\n<li>Robust 2025 revenue guidance ranging from $1.87 billion to $1.95 billion, reflecting continued momentum and growth potential.</li>\n<li>Expanded Medicare coverage for Signatera in non-small cell lung cancer, opening new market opportunities and potential revenue streams.</li>\n</ul>\n</p>\n\n<p>Additionally, several analysts have raised their price targets and reiterated Buy ratings on Natera's stock, citing the company's strong Q4 performance, promising growth prospects, and strategic initiatives. These positive analyst views have further fueled the stock's pre-market rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NTRA","symbol_name":"Natera, Inc.","start_time":0,"source_url":"","article_id":"1159773109","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159773109","pubTimestamp":1740753897,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Natera  stock surged 5.36% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and bullish 2025 guidance.The key highlights driving Natera's stock rally include:. Record revenue of $476 million in Q4 2024, reflecting a 53% year-over-year increase, driven by strong growth in their Signatera test volumes and improved average selling prices .Gross margins expanded significantly to 63% in Q4 2024, up from 51% in the prior year, showcasing improved ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NTRA":"Natera, Inc."},"translate_title":"股票赛道Natera盘前飙升5.36%，第四季度业绩创纪录，前景强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NTRA":1},"content_text":"Natera (NASDAQ: NTRA) stock surged 5.36% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and bullish 2025 guidance.\nThe key highlights driving Natera's stock rally include:\n\nRecord revenue of $476 million in Q4 2024, reflecting a 53% year-over-year increase, driven by strong growth in their Signatera test volumes and improved average selling prices (ASPs).\nGross margins expanded significantly to 63% in Q4 2024, up from 51% in the prior year, showcasing improved cost management and pricing strategies.\nPositive cash flow generation of $46 million in Q4 2024, contributing to a total of $86 million for the year, demonstrating Natera's financial strength.\nRobust 2025 revenue guidance ranging from $1.87 billion to $1.95 billion, reflecting continued momentum and growth potential.\nExpanded Medicare coverage for Signatera in non-small cell lung cancer, opening new market opportunities and potential revenue streams.\n\nAdditionally, several analysts have raised their price targets and reiterated Buy ratings on Natera's stock, citing the company's strong Q4 performance, promising growth prospects, and strategic initiatives. These positive analyst views have further fueled the stock's pre-market rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}